» Articles » PMID: 8418891

Effects of High-density Lipoprotein Particles Containing Apo A-I, with or Without Apo A-II, on Intracellular Cholesterol Efflux

Overview
Specialties Biochemistry
Biophysics
Date 1993 Jan 10
PMID 8418891
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Previous reports have shown a differential effect of high-density lipoprotein (HDL) particles which contain apolipoprotein (apo) A-I without apo A-II (Lp A-I) and particles containing both apo A-I and apo A-II (Lp A-I/A-II) on cholesterol efflux from the mouse adipocyte cell line Ob1771, with Lp A-I and Lp A-I/A-II being active and inactive cholesterol efflux promotors, respectively. The present study was conducted to examine the roles of these two populations of apo-specific HDL particles on reverse cholesterol transport from cholesterol-loaded human skin fibroblasts and bovine aortic endothelial cells. The ability of HDL particles to remove intracellular cholesterol was tested by measuring depletion of the substrate pool for acylCoA:cholesterol acyltransferase (ACAT) and efflux of newly synthesized cholesterol, while removal of plasma membrane cholesterol was assessed by measuring efflux of [3H]cholesterol from prelabeled cells. Lp A-I and Lp A-I/A-II isolated from HDL2, HDL3 or plasma by immunoaffinity techniques each decreased esterification of cholesterol by both fibroblasts and endothelial cells. A mixture of Lp A-I and Lp A-I/A-II isolated from HDL3 decreased cholesterol esterification by fibroblasts in an additive manner, thus demonstrating that Lp A-I/A-II did not inhibit Lp A-I-mediated cholesterol efflux. Both Lp A-I and Lp A-I/A-II promoted efflux of sterol newly synthesized by fibroblasts, and no significant differences were observed between the apo-specific particles. Apo-specific particles were also similarly effective at preventing the accumulation of LDL-derived cholesterol in cholesterol-depleted fibroblasts. Efflux of [3H]cholesterol from plasma membranes was stimulated to similar extents by Lp A-I and Lp A-I/A-II isolated from either HDL2, HDL3 or plasma. Thus, the apo-specific HDL particles Lp A-I and Lp A-I/A-II are both effective promoters of cholesterol efflux from fibroblasts and aortic endothelial cells.

Citing Articles

Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1.

Melchior J, Street S, Andraski A, Furtado J, Sacks F, Shute R J Lipid Res. 2017; 58(7):1374-1385.

PMID: 28476857 PMC: 5496035. DOI: 10.1194/jlr.M075382.


Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

Gomaraschi M, Ossoli A, Castelnuovo S, Simonelli S, Pavanello C, Balzarotti G J Lipid Res. 2017; 58(5):994-1001.

PMID: 28351888 PMC: 5408617. DOI: 10.1194/jlr.P072371.


Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

Wang Y, Niimi M, Nishijima K, Waqar A, Yu Y, Koike T Arterioscler Thromb Vasc Biol. 2012; 33(2):224-31.

PMID: 23241412 PMC: 3673010. DOI: 10.1161/ATVBAHA.112.300445.


Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

Sviridov D, Fidge N, Fielding C Biochem J. 2001; 358(Pt 1):79-86.

PMID: 11485554 PMC: 1222034. DOI: 10.1042/0264-6021:3580079.


Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Castellani L, Navab M, Van Lenten B, Hedrick C, Hama S, Goto A J Clin Invest. 1997; 100(2):464-74.

PMID: 9218525 PMC: 508211. DOI: 10.1172/JCI119554.